Terminal Diagnosis Transforms Man into Groundbreaking Liver Transplant Trailblazer

A man in London, who was given months to live due to liver cirrhosis and non-alcoholic fatty liver disease, has become the first patient in the world to receive an experimental liver transplant as part of a groundbreaking clinical trial called the DeFat study. The trial aims to make fatty livers more suitable for transplant by treating them with drugs and filtering out excess fat. Currently, a significant number of donated livers are declined and discarded due to excess fat, which reduces their viability. The trial offers hope for patients on the waiting list for liver transplants and could potentially open up new treatment options for liver-related conditions.